Cardinal Health, Inc.

🇺🇸New York Stock Exchange
Back to all articles
Cardinal Health, Inc. stock analysis CAH overview
Bullish +75

We Ran A Stock Scan For Earnings Growth And Cardinal Health (NYSE:CAH) Passed With Ease

🏥 Cardinal Health (NYSE:CAH) is highlighted as a profitable, growing company suitable for investors avoiding high-risk "story stocks."

💰 Earnings per share increased from US$5.41 to US$7.06 over the last year, representing a commendable 31% gain.

📈 Revenue grew by 10% to reach US$24 billion in the reported period.

📉 EBIT margins remained fairly unchanged during the last year despite revenue expansion.

📊 Three-year EPS growth rates are viewed as less indicative of future performance compared to recent growth metrics.

💼 Company insiders hold US$44 million worth of shares, demonstrating alignment with shareholder interests.

🔍 Analyst forecasts suggest Cardinal Health has promising growth potential and warrants further research by growth investors.

⚠️ The article notes there are two warning signs associated with Cardinal Health that investors need to consider.

Bullish Signals
  • Cardinal Health (NYSE:CAH) delivered impressive earnings per share (EPS) growth, with EPS soaring from US$5.41 to US$7.06 over the last year.
  • The company achieved a commendable 31% gain in EPS during the past year, demonstrating strong profitability and operational success.
  • Cardinal Health reported revenue growth of 10% for the period, reaching a total of US$245 billion.
  • Company insiders show alignment with shareholders through ownership of US$44 million worth of shares, indicating conviction in the business strategy.
  • The combination of solid EPS growth and insider investment positions Cardinal Health as a company worthy of further research for growth investors.
Risk Factors
  • Cardinal Health's EPS growth over the last three years is described as coming from a relatively low point, raising concerns that this historical rate isn't particularly indicative of expected future performance.
  • EBIT margins remained fairly unchanged over the last year, suggesting limited operational leverage or efficiency gains compared to revenue growth.
  • The article explicitly mentions there are 2 warning signs for Cardinal Health that need to be taken into consideration, though these specific risks are not detailed in the text.
  • Insider ownership accounts for only 0.09% of the company, which, while still a considerable amount ($44m), is noted as insufficient given the size of Cardinal Health to expect insiders to hold a significant proportion.
  • The article emphasizes that past performance should be weighed carefully against future outlooks, warning that base opinions on past growth rates alone may not be sufficient for investing decisions.
Full Analysis
The article analyzes Cardinal Health (NYSE:CAH) as an investment candidate characterized by its strong profitability and recent earnings growth, contrasting it with higher-risk "story stocks" that lack revenue. Over the past year, Cardinal Health's earnings per share (EPS) increased significantly from US$5.41 to US$7.06, representing a 31% gain. While the company has achieved impressive EPS growth over the last three years starting from a low point, the analysis suggests focusing on more recent performance metrics rather than historical averages for future expectations. Financial metrics indicate that Cardinal Health maintained relatively stable earnings before interest and tax (EBIT) margins over the last year while achieving a 10% revenue increase to US$245 billion. The article highlights insider ownership as a positive signal, noting that company insiders hold US$44 million worth of shares, which accounts for approximately 0.09% of the company but demonstrates alignment between management and shareholder interests. However, the text notes that there are two warning signs for Cardinal Health that investors should consider before making an investment decision. The analysis concludes that while relying solely on past performance has its limitations, Cardinal Health exhibits raw earnings growth rates that suggest a business worthy of further research, particularly for growth investors valuing solid EPS expansion and insider confidence. The article ultimately presents Cardinal Health as one of several US stocks with promising growth potential and insider conviction, advising readers to review detailed charts and interactive analyst forecasts available through Simply Wall St while emphasizing that the content is general commentary and not financial advice.